Geneva, Switzerland, September 5, 2018
Abologix has been selected to enter Fondation Eclosion, the Geneva Life Sciences incubator supported by the Republique et canton de Genève. Under the program Abologix will receive invaluable business, scientific and financial support.
“We are honoured and grateful to have been selected to participate in this incubation program. This will allow the company to access critical resources required for its growth. We hope to make a lasting contribution to the growth of the biotechnology ecosystem in the city of Geneva”.
said Ignacio Faus, co-founder and Chairman of the Board of Abologix.